Work

Abstract A042: Targeting a cancer-specific mitotic vulnerability in ovarian cancer by combining Mirvetuximab soravtansine with inhibitors of Polo-like kinase 1

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.ovarian25-a042

Authors: Jesse C. Patterson, Nabihah Tayob, Robin Lu, Yi Wen Kong, Brian A. Joughin, Eugene Kim, Bo Rueda, Joyce F. Liu, Ursula A. Matulonis, Meghan Shea, Michael B. Yaffe

Institutions: Koch Institute for Integrative Cancer Research At MIT, Massachusetts Institute of Technology, Dana-Farber Cancer Institute, Harvard University, Massachusetts General Hospital, Beth Israel Deaconess Medical Center

Language: English

Topic: Microtubule and mitosis dynamics

Subfield: Cell Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4414349643

Cites:

Cited by:

Related to: